19-1221961-A-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM1BP4BS2

The NM_000455.5(STK11):​c.875A>T​(p.Tyr292Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000426 in 1,409,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y292C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000043 ( 0 hom. )

Consequence

STK11
NM_000455.5 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 5.60

Publications

4 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 28 uncertain in NM_000455.5
BP4
Computational evidence support a benign effect (MetaRNN=0.3792882).
BS2
High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK11NM_000455.5 linkc.875A>T p.Tyr292Phe missense_variant Exon 7 of 10 ENST00000326873.12 NP_000446.1 Q15831-1A0A0S2Z4D1
STK11NM_001407255.1 linkc.875A>T p.Tyr292Phe missense_variant Exon 7 of 9 NP_001394184.1
STK11NR_176325.1 linkn.2142A>T non_coding_transcript_exon_variant Exon 8 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK11ENST00000326873.12 linkc.875A>T p.Tyr292Phe missense_variant Exon 7 of 10 1 NM_000455.5 ENSP00000324856.6 Q15831-1
STK11ENST00000652231.1 linkc.875A>T p.Tyr292Phe missense_variant Exon 7 of 9 ENSP00000498804.1 Q15831-2
STK11ENST00000585748.3 linkc.503A>T p.Tyr168Phe missense_variant Exon 9 of 12 3 ENSP00000477641.2 A0A087WT72
STK11ENST00000593219.6 linkn.*700A>T non_coding_transcript_exon_variant Exon 8 of 11 3 ENSP00000466610.1 K7EMR0
STK11ENST00000593219.6 linkn.*700A>T 3_prime_UTR_variant Exon 8 of 11 3 ENSP00000466610.1 K7EMR0

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.0000117
AC:
2
AN:
170906
AF XY:
0.0000109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000142
Gnomad OTH exome
AF:
0.000215
GnomAD4 exome
AF:
0.00000426
AC:
6
AN:
1409910
Hom.:
0
Cov.:
30
AF XY:
0.00000287
AC XY:
2
AN XY:
696742
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31998
American (AMR)
AF:
0.00
AC:
0
AN:
37480
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25332
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36402
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79946
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5704
European-Non Finnish (NFE)
AF:
0.00000552
AC:
6
AN:
1086048
Other (OTH)
AF:
0.00
AC:
0
AN:
58426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.0000434
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Peutz-Jeghers syndrome Uncertain:3
Oct 06, 2023
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces tyrosine with phenylalanine at codon 292 of the STK11 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with STK11-related disorders in the literature. This variant has been identified in 2/170906 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Jun 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces tyrosine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 292 of the STK11 protein (p.Tyr292Phe). This variant is present in population databases (rs587780011, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 127706). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Feb 26, 2014
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is denoted STK11 c.875A>T at the cDNA level, p.Tyr292Phe (Y292F) at the protein level, and results in the change of a Tyrosine to a Phenylalanine (TAC>TTC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. STK11 Tyr292Phe was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Tyrosine and Phenylalanine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution and is likely to affect protein integrity. STK11 Tyr292Phe occurs at a position that is well conserved across species and is located in the Protein Kinase domain (UniProt). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available information, it is unclear whether STK11 Tyr292Phe is pathogenic or benign. We consider it to be a variant of uncertain significance. -

Hereditary cancer-predisposing syndrome Uncertain:1
Nov 08, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Y292F variant (also known as c.875A>T), located in coding exon 7 of the STK11 gene, results from an A to T substitution at nucleotide position 875. The tyrosine at codon 292 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
0.0090
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
20
DANN
Benign
0.88
DEOGEN2
Benign
0.28
T;T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.38
T;T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
-0.095
.;N
PhyloP100
5.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.2
.;N
REVEL
Uncertain
0.41
Sift
Benign
0.64
.;T
Sift4G
Benign
0.69
T;T
Polyphen
0.040
.;B
Vest4
0.67
MutPred
0.40
Loss of phosphorylation at Y292 (P = 0.0368);Loss of phosphorylation at Y292 (P = 0.0368);
MVP
0.73
MPC
0.060
ClinPred
0.26
T
GERP RS
3.6
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.0
Varity_R
0.28
gMVP
0.61
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780011; hg19: chr19-1221960; API